• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Actin filament-associated protein 1-like 1 (AFAP1L1)

ACP13008

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP13008 Target NameAFAP1L1
Target SynonymsActin filament-associated protein 1-like 1; AF1L1_HUMAN; AFAP1-like protein 1; Afap1l1; AI173486; RGD1311580FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-768
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8TED9
Background Information
  • Uniprot Id

    Q8TED9

  • Target Species

    Human

  • Target Name

    AFAP1L1

  • Target Full Name

    Actin filament-associated protein 1-like 1

  • Target Function

    May be involved in podosome and invadosome formation.

  • Target Subcellular Location

    Cytoplasm. Cell projection, podosome. Cell projection, invadopodium. Cytoplasm, cytoskeleton, stress fiber.

  • Target Tissue Specificity

    Expressed in breast, colon and brain. In all 3 tissues, expressed in the microvasculature (at protein level). In addition, in the breast, found in the contractile myoepithelial cell layer which surrounds the breast ducts (at protein level). In the colon,

  • Target Synonyms

    Actin filament-associated protein 1-like 1; AF1L1_HUMAN; AFAP1-like protein 1; Afap1l1; AI173486; RGD1311580

Inquire Recombinant Human Actin filament-associated protein 1-like 1 (AFAP1L1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification